Studies by Fridlender et al. showcased that blocking TGF-β facilitates neutrophil recruitment, thereby exhibiting anti-tumor activity by supporting cytotoxic T cell-mediated responses [36,165]. The gene discussed is TGFB1; the disease is neoplasm.